Abstract
Policy decisions on COVID-19 interventions should be informed by a local, regional and national understanding of SARS-CoV-2 transmission. Epidemic waves may result when restrictions are lifted or poorly adhered to, variants with new phenotypic properties successfully invade, or when infection spreads to susceptible sub-populations. Three COVID-19 epidemic waves have been observed in Kenya. Using a mechanistic mathematical model we explain the first two distinct waves by differences in contact rates in high and low social-economic groups, and the third wave by the introduction of a new higher-transmissibility variant. Reopening schools led to a minor increase in transmission between the second and third waves. Our predictions of current population exposure in Kenya (∼75% June 1st) have implications for a fourth wave and future control strategies.
One Sentence Summary COVID-19 spread in Kenya is explained by mixing heterogeneity and a variant less constrained by high population exposure
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by the UK Foreign, Commonwealth and Development Office (FCDO) and Wellcome Trust [220985/Z/20/Z]; National Institute for Health Research (NIHR) Global Health Research Project GeMVi [17/63/82] and NIHR Global Health Research Unit on Mucosal Pathogens [16/136/46] JO, using UK Aid from the UK Government to support global health research; Wellcome Trust Intermediate Fellowship awards [201866, 107568] EAO, LIOO; MRC/DFID African Research Leader Fellowship [MR/S005293/1] IMOA, CM; DFID/MRC/NIHR/Wellcome Trust Joint Global Health Trials Award [MR/R006083/1] AA; Wellcome Trust Senior Research Fellowship [214320] and the NIHR Health Protection Research Unit in Immunisation JAGS; Wellcome Trust [220991/Z/20/Z and 203077/Z/16/Z] GMW; UKRI through the JUNIPER modelling consortium [grant number MR/V038613/1]
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
N/A
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All code and data for the transmission model underlying this study is accessible at the github repository https://github.com/SamuelBrand1/kenya-covid-three-waves. All data is available in the main text or the supplementary materials.